-
Endothelial Cell TRPV4 Channels Turn to the Dark Side During Hypertension. Hypertension (IF 6.9) Pub Date : 2024-12-18 Alejandro Mata-Daboin,Jonathan H Jaggar
-
Maternal Hypertension Aggravates Vascular Dysfunction After Injury in Male Adult Offspring Through Transgenerational Transmission of N6-Methyladenosine. Hypertension (IF 6.9) Pub Date : 2024-12-17 Dezhong Zheng,Jiayi Jiang,Anna Shen,Yixiang Zhong,Yi Zhang,Jiancheng Xiu
BACKGROUND Whether maternal hypertension contributes to the enhanced susceptibility to vascular remodeling in adult offspring through epigenetic mechanisms remains unclear. We aimed to address this gap in the literature using a transgenerational mouse model. METHODS Gestational hypertension was induced in pregnant mice using chronic angiotensin II infusion. Blood pressure was monitored using the tail-cuff
-
Baroreflex Sensitivity and Long-Term Dementia Risk in Older Adults. Hypertension (IF 6.9) Pub Date : 2024-12-13 Yuan Ma,Yiwen Zhang,Rikuta Hamaya,Berend E Westerhof,Hossam A Shaltout,Maryam Kavousi,Francesco Mattace-Raso,Albert Hofman,Frank J Wolters,Lewis A Lipsitz,M Arfan Ikram
BACKGROUND Increased blood pressure (BP) variability is linked to dementia risk, but the relationship between baroreflex sensitivity (BRS), a fundamental mechanism for maintaining stable BP, and dementia risk is undetermined. METHODS We tested the hypothesis that impaired BRS is associated with increased dementia risk in 1819 older adults (63% women; age, 71.0±6.3 years) from the community-based Rotterdam
-
Cardiac cGMP Regulation and Therapeutic Applications. Hypertension (IF 6.9) Pub Date : 2024-12-11 Sumita Mishra,Vivek Chander,David A Kass
cGMP plays a central role in cardiovascular regulation in health and disease. It is synthesized by NO or natriuretic peptide activated cyclases and hydrolyzed to 5'GMP by select members of the PDEs (phosphodiesterase) superfamily. The primary downstream effector is cGMP-dependent protein kinase, primarily cGK-1a also known as protein kinase G 1a in the heart and vasculature. cGMP signaling is controlled
-
Characterizing the Origins of Primary Aldosteronism. Hypertension (IF 6.9) Pub Date : 2024-12-11 Jenifer M Brown,Brooke Honzel,Laura C Tsai,Julia Milks,Yvonne Neibuhr,Andrew J Newman,Michael Cherney,David Stouffer,Richard J Auchus,Anand Vaidya
BACKGROUND Renin-independent aldosterone production in normotensive people increases risk for developing hypertension. In parallel, normotensive adrenal glands frequently harbor aldosterone-producing micronodules with pathogenic somatic mutations known to induce primary aldosteronism (PA). A deeper understanding of these phenomena would inform the origins of PA and its role in hypertension pathogenesis
-
Burden of Cardio-Cerebrovascular and Renal Diseases Attributable to Systolic Hypertension in France in 2021. Hypertension (IF 6.9) Pub Date : 2024-12-09 Clémence Grave,Christophe Bonaldi,Laure Carcaillon-Bentata,Amélie Gabet,Jean-Michel Halimi,Christophe Tzourio,Yannick Béjot,Marion J Torres,Philippe Gabriel Steg,Isabelle Durand Zaleski,Jacques Blacher,Valérie Olié
BACKGROUND Hypertension is the most common chronic disease and a major modifiable risk factor for cardio-cerebrovascular and renal diseases. This study estimated the national burden of hypertension, defined as systolic blood pressure ≥140 mm Hg, on morbidity and mortality in 2021 in France. METHODS For all diseases causally associated with hypertension (cardiovascular diseases, chronic kidney diseases
-
Cross-Sex Hormone Therapy Is Associated With Loss of Circadian Rhythm in the Male Rat. Hypertension (IF 6.9) Pub Date : 2024-12-05 Jordan H Mallette,Breland F Crudup,Adrian Oudomrath Speyrer,Adam Z Rawls,Kathy Cockrell,Alex T Willis,Kacey Davenport,Licy L Yanes Cardozo,Noha M Shawky,Barbara T Alexander
BACKGROUND Transgender women are individuals born male but identify as female. Many transgender women undergo gender-affirming hormone therapy to alleviate the distress that can occur due to gender incongruence. For transgender women, gender-affirming hormone therapy includes 17β-estradiol (E2) combined with an antiandrogen therapy (AA) or surgical intervention. Numerous studies suggest that the risk
-
Ang-(1-7) and ET-1 Interplay Through Mas and ETB Receptor Interaction Defines a Novel Vasoprotective Mechanism. Hypertension (IF 6.9) Pub Date : 2024-12-05 Augusto C Montezano,Jithin Kuriakose,Katie Y Hood,Yuan Yan Sin,Livia L Camargo,Yoon Namkung,Carlos H Castro,Robson A Santos,Rheure Alves-Lopes,Gonzalo Tejeda,Patricia Passaglia,Sehrish Basheer,Emily Gallen,Jane E Findlay,Fazli R Awan,Stéphane A Laporte,Margaret R MacLean,George S Baillie,Rhian M Touyz
BACKGROUND Ang-(1-7) (angiotensin (1-7)) via MasR (Mas receptor) opposes vaso-injurious actions of Ang II (angiotensin II) as shown in models of pulmonary hypertension. The underlying mechanisms remain unclear. We hypothesized cross talk between Ang-(1-7) and the protective arm of the ET-1 (endothelin-1) system involving MasR and ETBR (endothelin receptor type B). METHODS/RESULTS To address this, we
-
Cost-Effectiveness of Intensive Blood Pressure Control in Youth With Chronic Kidney Disease. Hypertension (IF 6.9) Pub Date : 2024-12-05 Carol L Vincent,Katherine A Poehling,Joseph Rigdon,Christopher L Schaich,Andrew M South,Stephen M Downs
BACKGROUND Intensive blood pressure (BP) control in youth with chronic kidney disease (CKD) slows progression, delaying the need for kidney replacement therapy (KRT). Most youth with CKD have hypertension and BP control is difficult to achieve outside of controlled experimental settings. Implementing effective BP control strategies in this population may be cost-saving despite requiring additional
-
Orthostatic and Standing Hypertension and Risk of Cardiovascular Disease. Hypertension (IF 6.9) Pub Date : 2024-12-05 Sean W Dooley,Fredrick Larbi Kwapong,Hannah Col,Ruth-Alma N Turkson-Ocran,Long H Ngo,Jennifer L Cluett,Kenneth J Mukamal,Lewis A Lipsitz,Mingyu Zhang,Natalie R Daya,Elizabeth Selvin,Pamela L Lutsey,Josef Coresh,Beverly Gwen Windham,Lynne Wagenknecht,Stephen P Juraschek
BACKGROUND Orthostatic hypertension is an emerging risk factor for adverse events. Recent consensus statements combine an increase in blood pressure upon standing with standing hypertension, but whether these 2 components have similar risk associations with cardiovascular disease (CVD) is unknown. METHODS The ARIC study (Atherosclerosis Risk in Communities) measured supine and standing blood pressure
-
ACE2, From the Kidney to SARS-CoV-2: Donald Seldin Award Lecture 2023. Hypertension (IF 6.9) Pub Date : 2024-12-03 Daniel Batlle,Luise Hassler,Jan Wysocki
ACE2 (angiotensin-converting enzyme 2) is a monocarboxypeptidase that cleaves Ang II (angiotensin II) among other substrates. ACE2 is present in the cell membrane of many organs, most abundantly in epithelial cells of kidney proximal tubules and the small intestine, and also exists in soluble forms in plasma and body fluids. Membrane-bound ACE2 exerts a renoprotective action by metabolizing Ang II
-
Identification of Circulating Proteins Associated With Blood Pressure. Hypertension (IF 6.9) Pub Date : 2024-12-03 Siqi Xu,Simin Wen,Xizeng Zong,Shifeng Wen,Jianwei Zhu,Weipeng Zheng,Zhiqiang Wang,Peihua Cao,Zhijiang Liang,Changhai Ding,Yan Zhang,Guangfeng Ruan
BACKGROUND Circulating proteins in blood are involved in various physiological processes, but their contributions to blood pressure regulation remain partially understood. In traditional observational studies, identifying circulating proteins causally associated with blood pressure is challenging because of potentially unmeasured confounding and possible reverse causality. METHODS Two-sample Mendelian
-
Peli1 Deficiency in Macrophages Attenuates Pulmonary Hypertension by Enhancing Foxp1-Mediated Transcriptional Inhibition of IL-6. Hypertension (IF 6.9) Pub Date : 2024-12-02 Donghai Lin,Li Hu,Dong Wei,Yan Li,Yanfang Yu,Qiang Wang,Xiaoxuan Sun,Yueyao Shen,Youjia Yu,Kai Li,Zhiwei Zhang,Yue Cao,Jiantao Li,Yuehua Li,David Fulton,Jingyu Chen,Jie Wang,Huijie Huang,Feng Chen
BACKGROUND The infiltration of macrophages into the lungs is a common characteristic of perivascular inflammation, contributing to vascular remodeling in pulmonary hypertension (PH). Peli1 (pellino E3 ubiquitin-protein ligase 1) plays a critical role in regulating the production of proinflammatory cytokines and the polarization of macrophages in various diseases. However, the role of Peli1 in PH remains
-
ATP2A3 in Primary Aldosteronism: Machine Learning-Based Discovery and Functional Validation. Hypertension (IF 6.9) Pub Date : 2024-12-02 Zhuolun Sun,Elisabeth Kemter,Yingxian Pang,Martin Bidlingmaier,Eckhard Wolf,Martin Reincke,Tracy Ann Williams
BACKGROUND Aldosterone-producing adenomas (APAs) are a common cause of primary aldosteronism that can lead to cardiovascular complications if left untreated. Machine learning-based bioinformatics approaches have emerged as powerful tools for identifying potential disease markers, gaining widespread recognition in biomedical research. We aimed to use machine learning to discover novel biomarkers of
-
Definitive Evidence for the Identification and Function of Renin-Expressing Cholinergic Neurons in the Nucleus Ambiguus. Hypertension (IF 6.9) Pub Date : 2024-12-02 Éva M Fekete,Javier Gomez,Mina Ghobrial,Kathren Kaminski,Patricia C Muskus,Carie R Boychuk,Ana Hantke Guixa,Ibrahim Vazirabad,Michelle Xie,Azeez Ganiyu,Daria Golosova,Natalia M Mathieu,Yoko B Wang,Ko-Ting Lu,Kelsey K Wackman,Daniel T Brozoski,Gary C Mouradian,Matthew R Hodges,Jeffrey L Segar,Justin L Grobe,Curt D Sigmund,Pablo Nakagawa
BACKGROUND The importance of the brain renin-angiotensin system in cardiovascular function is well accepted. However, not knowing the precise source of renin in the brain has been a limitation toward a complete understanding of how the brain renin-angiotensin system operates. METHODS Highly sensitive in situ hybridization techniques and conditional knockout mice were used to address the location and
-
Caregiving and Hypertension in Younger Black Women: The Jackson Heart Study. Hypertension (IF 6.9) Pub Date : 2024-11-27 Milla Arabadjian,Yiwei Li,Byron Jaeger,Calvin L Colvin,Jolaade Kalinowski,Miriam A Miles,Lenette M Jones,Jacquelyn Y Taylor,Kenneth Butler,Paul Muntner,Tanya M Spruill
BACKGROUND Caregiving has been associated with high blood pressure in middle-aged and older women, but this relationship is understudied among younger Black women, a population at high risk for hypertension. We examined the associations of caregiving stress and caregiving for high-needs dependents with incident hypertension among reproductive-age women in the JHS (Jackson Heart Study), a cohort of
-
Home Blood Pressure Measurements Are Not Performed According to Guidelines and Standardized Education Is Urgently Needed. Hypertension (IF 6.9) Pub Date : 2024-11-25 Eleanor Clapham,Dean S Picone,Samuel Carmichael,George S Stergiou,Norm R C Campbell,John Stevens,Carol Batt,Aletta E Schutte,Niamh Chapman
BACKGROUND Patient education is needed to perform home blood pressure measurement (HBPM) according to blood pressure (BP) guidelines. It is not known how BP is measured at home and what education is provided, which was the aim of the study. METHODS Mixed-methods study among Australian adults who perform HBPM (June to December 2023). Participants completed a 30-item online survey on whether they followed
-
Cerebral Blood Flow Dynamics in Neurogenic Orthostatic Hypotension: A Systematic Review and Meta-Analysis. Hypertension (IF 6.9) Pub Date : 2024-11-21 Jacquie R Baker,Paul A Beach,Shaun I Ranada,Aishani Patel,Jennifer Gewandter,Can Ozan Tan,Roy Freeman,Satish R Raj
BACKGROUND Neurogenic orthostatic hypotension (nOH) causes pathological falls in standing blood pressure that may or may not be symptomatic. nOH also raises the risk of poor neurological outcomes irrespective of symptom presence, possibly reflecting subclinical cerebral hypoperfusion. Dynamic changes in cerebral blood flow velocity (CBFv) help infer how blood pressure fluctuations influence CBFv and
-
Response of Blood Pressure to Renal Denervation Is Not Associated With Genetic Variants. Hypertension (IF 6.9) Pub Date : 2024-11-21 Christian Delles,Roland E Schmieder,Rónán Daly,Dennis Kannenkeril,Agnes Bosch,Lucas Lauder,Michael Kunz,Michael Böhm,Graham Hamilton,Raphael S Schmieder,Axel Schmid,Pawel Herzyk,Felix Mahfoud
BACKGROUND Renal denervation lowers blood pressure (BP) in patients with uncontrolled hypertension. We conducted an unbiased genomic screen to identify genetic variants that may associate with BP response to renal denervation (RDN). METHODS Patients (n=268) with uncontrolled resistant hypertension (baseline BP, 166±21/90±15 mm Hg) who underwent endovascular RDN using the Symplicity catheter (Medtronic
-
Correction to: Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial. Hypertension (IF 6.9) Pub Date : 2024-11-20
-
Left Ventricular Hypertrophy in Women With a History of Preeclampsia. Hypertension (IF 6.9) Pub Date : 2024-11-14 Maria G Hauge,Peter Damm,Klaus F Kofoed,Emma Louise Ries Møller,Andrea G Lopez,Anne S Ersbøll,Marianne Johansen,Per E Sigvardsen,Michael H C Pham,Jens P Goetze,Andreas Fuchs,Jørgen T Kühl,Børge G Nordestgaard,Lars V Køber,Finn Gustafsson,Jesper J Linde
BACKGROUND As a hypertensive disorder of pregnancy, preeclampsia is associated with increased cardiovascular morbidity and mortality later in life. Since early signs of myocardial affection could indicate a higher risk of future cardiovascular disease manifestations, we investigated whether women with prior preeclampsia have a higher prevalence of left ventricular hypertrophy compared with women from
-
Irisin Improves Preeclampsia by Promoting Embryo Implantation and Vascular Remodeling. Hypertension (IF 6.9) Pub Date : 2024-11-14 Dawei Zhu,Jie Huang,Yujie Wu,Lin Fan,Yijun Liu,Qianwen Zhang,Li Li,Jian Han,Xinghui Liu
BACKGROUND Preeclampsia is a pregnancy-specific disorder with unclear pathogenesis. Irisin, a recently identified exercise-induced factor, significantly influences lipid metabolism and cardiovascular function. Nonetheless, its role in trophoblast development during human placentation and the related intracellular signaling pathways remain poorly understood. METHODS We assessed peripheral blood irisin
-
Reproducibility and Treatment Effect on Office and Ambulatory Pressure Relation. Hypertension (IF 6.9) Pub Date : 2024-11-14 Giuseppe Mancia,Rita Facchetti,Fosca Quarti-Trevano,Guido Grassi
BACKGROUND In the absence of outcome-based ambulatory blood pressure (BP) trails hypertension guidelines provide 24-hour mean BP values corresponding to trial-validated office BP values. Data are shown for untreated and treated patients together, but whether corresponding ambulatory values are similar in untreated and treated hypertensives and reproducible at yearly measurements during treatment is
-
Exposure to Volatile Organic Compounds and Blood Pressure in NHANES 2011 to 2018. Hypertension (IF 6.9) Pub Date : 2024-11-13 Katlyn E McGraw,Arce Domingo-Relloso,Daniel W Riggs,Danielle N Medgyesi,Raghavee Neupane,Jeanette A Stingone,Tiffany R Sanchez
BACKGROUND Volatile organic compounds (VOCs) are ubiquitous environmental pollutants. Exposure to VOCs is associated with cardiovascular disease risk factors, including elevated blood pressure in susceptible populations. However, research in the general population, particularly among nonsmoking adults, is limited. We hypothesized that higher VOC exposure is associated with higher blood pressure and
-
Mechanistic Insights Into Redox Damage of the Podocyte in Hypertension. Hypertension (IF 6.9) Pub Date : 2024-11-13 Daria V Ilatovskaya,Amanda Behr,Alexander Staruschenko,Gentzon Hall,Oleg Palygin
Podocytes are specialized cells within the glomerular filtration barrier, which are crucial for maintaining glomerular structural integrity and convective ultrafiltration. Podocytes exhibit a unique arborized morphology with foot processes interfacing by slit diaphragms, ladder-like, multimolecular sieves, which provide size and charge selectivity for ultrafiltration and transmembrane signaling. Podocyte
-
Genetics of Hypertension: Additive and Interactive Effects. Hypertension (IF 6.9) Pub Date : 2024-11-11 Zdenka Pausova,Johanne Tremblay,Pavel Hamet
-
Blood Pressure Regulation in Post-COVID POTS: Beyond Sinus Tachycardia. Hypertension (IF 6.9) Pub Date : 2024-11-11 Madeleine Johansson,Marcus Ståhlberg,Fabrizio Ricci,Christian Lewinter,Viktor Hamrefors,Peter M Nilsson,Richard Sutton,Artur Fedorowski
BACKGROUND Postural orthostatic tachycardia syndrome (POTS) is a frequently diagnosed cardiovascular disorder after COVID-19 infection. POTS is characterized by the presence of excessive sinus tachycardia on standing without a fall in blood pressure (BP). We investigated the BP profile using 24-hour ambulatory BP monitoring in patients with new-onset POTS after COVID-19 compared with prepandemic population-based
-
Rhythmic Contractions of Lymph Vessels and Lymph Flow Are Disrupted in Hypertensive Rats. Hypertension (IF 6.9) Pub Date : 2024-11-06 Soumiya Pal,Ashim K Bagchi,David S Henry,Reid D Landes,Shengyu Mu,Sung W Rhee,Nancy J Rusch,Amanda J Stolarz
BACKGROUND Hypertension increases the risk of lymphedema in patients with comorbidities, but whether hypertension directly compromises lymph vessel (LV) function and lymph flow is unclear. We compared the contractions of mesenteric LVs ex vivo and lymph flow in vivo between normotensive and Ang II (angiotensin II)-induced hypertensive rats and explored the ionic basis of contractile patterns. Key studies
-
Evolutionary Characteristics in Primary Aldosteronism Patients. Hypertension (IF 6.9) Pub Date : 2024-11-06 Yinjie Gao,Yu Wang,Yue Zhou,Xiaoyan Chang,Yushi Zhang,Min Nie,Anli Tong
BACKGROUND Primary aldosteronism is predominantly caused by excessive aldosterone production from the adrenal cortex, and the aldosterone-producing structures could take many forms, like adenomas, nodules, micronodules, and so on. Most studies of primary aldosteronism were limited to the hotspot driver genes responsible for autonomous aldosterone production; however, the panoramic genetic architecture
-
Cost-Effectiveness of Salt Substitution and Antihypertensive Drug Treatment in Chinese Prehypertensive Adults. Hypertension (IF 6.9) Pub Date : 2024-10-28 Zhijia Sun,Haijun Zhang,Yinqi Ding,Canqing Yu,Dianjianyi Sun,Yuanjie Pang,Pei Pei,Ling Yang,Yiping Chen,Huaidong Du,Weijie Hu,Daniel Avery,Junshi Chen,Zhengming Chen,Liming Li,Jun Lv,
BACKGROUND Recent guidelines recommend antihypertensive drug treatment for prehypertensive individuals with blood pressure between 130/80 and 139/89 mm Hg. This study evaluates the cost-effectiveness of 3 interventions in Chinese prehypertensive adults: salt substitution, antihypertensive drug treatment, and their combination. METHODS We developed a Markov cohort model to estimate cardiovascular disease
-
Self-Guided Blood Pressure Screening in the Community: Opportunities, and Challenges. Hypertension (IF 6.9) Pub Date : 2024-10-25 Edel T O'Hagan,Simone L Marschner,Shiva Mishra,Haeri Min,Aletta E Schutte,Markus P Schlaich,Patrick Hannebery,Noel Duncan,Tim Shaw,Clara K Chow
BACKGROUND Community-based health check kiosks provide opportunities to improve the detection and long-term monitoring of hypertension. We describe the sociodemographic and cardiovascular characteristics of first-time and repeat users of these kiosks. METHOD This was an observational study. Deidentified data collected from 430 SiSU Health consumer-facing health check stations in pharmacies across Australia
-
20-HETE, Blood Pressure, and Vascular Stiffness in Young Adults. Hypertension (IF 6.9) Pub Date : 2024-10-23 Anne E Barden,Sujata Shinde,Lawrence J Beilin,Michael Phillips,Brendan Adler,Trevor A Mori
BACKGROUND Cytochrome-P450 eicosanoids from arachidonic acid, including vasodilator epoxyeicosatrienoic acids (EETs) and the vasoconstrictor 20-HETE, are important in regulating blood pressure, vascular tone, and cardiac and renal function. This study examined plasma 20-HETE and EETs in relation to blood pressure and vascular stiffness in a cohort of 1054 community-dwelling young adults from the Raine
-
Senescent Syncytiotrophoblast Secretion During Early Onset Preeclampsia. Hypertension (IF 6.9) Pub Date : 2024-10-23 Olivia Nonn,Olivia Debnath,Daniela S Valdes,Katja Sallinger,Ali Kerim Secener,Cornelius Fischer,Sebastian Tiesmeyer,Jose Nimo,Thomas Kuenzer,Juliane Ulrich,Theresa Maxian,Martin Knöfler,Philipp Karau,Hendrik Bartolomaeus,Thomas Kroneis,Alina Frolova,Lena Neuper,Nadine Haase,Alexander Malt,Niklas Müller-Bötticher,Kristin Kräker,Sarah Kedziora,Désirée Forstner,Roland Eils,Ruth Schmidt-Ullrich,Sandra
BACKGROUND Preeclampsia is a severe hypertensive disorder in pregnancy that causes preterm delivery, maternal and fetal morbidity, mortality, and life-long sequelae. Understanding the pathogenesis of preeclampsia is a critical first step toward protecting mother and child from this syndrome and increased risk of cardiovascular disease later in life. However, effective early predictive tests and therapies
-
Renal Denervation Lowers Nighttime Blood Pressure in True Resistant Hypertension. Hypertension (IF 6.9) Pub Date : 2024-10-21 Kazuomi Kario,David E Kandzari,Felix Mahfoud,Michael A Weber,Roland E Schmieder,Konstantinos Tsioufis,Minglei Liu,Michael Böhm,Raymond R Townsend
-
8-Aminopurines: A Promising New Direction for Purine-Based Therapeutics. Hypertension (IF 6.9) Pub Date : 2024-10-21 Edwin K Jackson,Stevan P Tofovic,Yuanyuan Chen,Lori A Birder
-
Somatic GNAQ, CTNNB1, and CACNA1C Mutations in Cat Aldosterone-Secreting Tumors. Hypertension (IF 6.9) Pub Date : 2024-10-21 Alice Watson,Harriet Syme,Morris Brown
BACKGROUND Primary aldosteronism (PA) is a common cause of human hypertension. Somatic mutations in KCNJ5, CACNA1D, ATP1A1, and ATP2B3 are found in at least 80% of aldosterone-producing adenomas, which cause unilateral PA in humans. Somatic mutations have been identified infrequently in 7 other genes; few of these were known to play a role in aldosterone secretion before the discovery of their mutations
-
Ultra-Processed Food Consumption and Hypertension Risk in the REGARDS Cohort Study. Hypertension (IF 6.9) Pub Date : 2024-10-17 Carol R Oladele,Neha Khandpur,Spencer Johnson,Ya Yuan,Vivien Wambugu,Timothy B Plante,Gina S Lovasi,Suzanne Judd
BACKGROUND This study examined the longitudinal association between ultraprocessed food (UPF) consumption and overall hypertension risk and explored the contribution of UPF to racial disparities in hypertension risk. METHODS We analyzed data from 5957 participants from the REGARDS cohort study (Reasons for Geographic and Racial Disparities in Stroke) who were free from hypertension during visit 1 (2003-2007)
-
Circulating miRNAs and Machine Learning for Lateralizing Primary Aldosteronism. Hypertension (IF 6.9) Pub Date : 2024-10-17 Bálint Vékony,Gábor Nyirő,Zoltan Herold,János Fekete,Filippo Ceccato,Sven Gruber,Lydia Kürzinger,Mirko Parasiliti-Caprino,Fabio Bioletto,Nikolette Szücs,Attila Doros,Bálint Kende Szeredás,Siti Khadijah Syed Mohammed Nazri,Vanessa Fell,Mohamed Bassiony,Magdolna Dank,Elena Aisha Azizan,Irina Bancos,Felix Beuschlein,Peter Igaz
BACKGROUND Distinguishing between unilateral and bilateral primary aldosteronism, a major cause of secondary hypertension, is crucial due to different treatment approaches. While adrenal venous sampling is the gold standard, its invasiveness, limited availability, and often difficult interpretation pose challenges. This study explores the utility of circulating microRNAs (miRNAs) and machine learning
-
Tackling POTS Needs More Than Just a Sympathetic Approach. Hypertension (IF 6.9) Pub Date : 2024-10-16 Melanie Dani,Artur Fedorowski
-
Young Athlete With Hypertension and Hypokalemia. Hypertension (IF 6.9) Pub Date : 2024-10-16 Antoine-Guy Lopez,Dominique Guerrot
We describe a 17-year-old woman diagnosed with severe hypertension during routine follow-up after the prescription of a combined oral contraceptive pill. Initially, due to her age, the estradiol-containing contraception, and high-level sport practice, physicians suspected drug-induced hypertension. Blood tests showed hypokalemia, and further investigations revealed pseudoaldosteronism. After the exclusion
-
Pediatric High Blood Pressure Recognition Associated With Electronic Decision Support: A Cohort Analysis. Hypertension (IF 6.9) Pub Date : 2024-10-16 Justin P Zachariah,Tavleen Singh,Shannon Collinson,Justin Rahman,Alisa A Acosta,Jessica F Campbell,Mary Hoang,Katharine E Sigler,Elizabeth A Onugha,Shweta S Shah,S Kristen Sexson-Tejtel,Mark Farrior,Scott Watson
BACKGROUND Pediatric high blood pressure (BP) predicts future cardiovascular disease events. High BP is improperly measured, underrecognized, and undermanaged especially in disadvantaged populations. In a large, diverse, academic pediatric practice, we detail the associations of a comprehensive initiative with high BP provider recognition. METHODS A comprehensive BP initiative was promulgated including
-
Transient High Salt Intake Promotes T-Cell-Mediated Hypertensive Vascular Injury. Hypertension (IF 6.9) Pub Date : 2024-10-16 Mina Yakoub,Masudur Rahman,Patricia Kleimann,Jasmina Hoffe,Milena Feige,Pascal Bouvain,Christina Alter,Jennifer Isabel Kluczny,Sophia Reidel,Rianne Nederlof,Lydia Hering,Doron Argov,Denada Arifaj,Marta Kantauskaite,Jaroslawna Meister,Markus Kleinewietfeld,Lars Christian Rump,Jonathan Jantsch,Ulrich Flögel,Dominik N Müller,Sebastian Temme,Johannes Stegbauer
BACKGROUND Dietary high salt (HS) intake has a strong impact on cardiovascular diseases. Here, we investigated the link between HS-aggravated immune responses and the development of hypertensive vascular disease. METHODS ApolipoproteinE-deficient mice were transiently treated with HS (1% NaCl) via drinking water for 2 weeks, followed by a washout period, and subsequent Ang II (angiotensin II) infusion
-
Evidence for Baroreceptor Activity During Carotid Artery Applanation. Hypertension (IF 6.9) Pub Date : 2024-10-16 Joshua M Cherubini,Genie J Y Lau,Elric Y Allison,Maureen J MacDonald
-
Postpartum Blood Pressure Variability and Heart Rate Variability in Preeclampsia. Hypertension (IF 6.9) Pub Date : 2024-10-15 Anne-Sophie van Wingerden,Maria Katsidoniotaki,Noora Haghighi,Casandra Almonte,Helen Woolcock Martinez,Eduard Valdes,Pedro Castro,Aymen Alian,Whitney Booker,Natalie A Bello,Randolph S Marshall,Ioannis A Kougioumtzoglou,Nils H Petersen,Eliza C Miller
BACKGROUND Preeclampsia is associated with autonomic dysregulation during pregnancy; however, less is known about autonomic function in the first week postpartum after preeclampsia. METHODS We retrospectively analyzed data from a prospective cohort of women with and without preeclampsia. Continuous blood pressure and heart rate were measured with finger plethysmography within 7 days postpartum. Frequency-domain
-
Cathepsin L Promotes Pulmonary Hypertension via BMPR2/GSDME-Mediated Pyroptosis. Hypertension (IF 6.9) Pub Date : 2024-10-15 Zhouyangfan Peng,Xue-Yang Luo,Xinyi Li,Yapei Li,Yusi Wu,Yuyang Tian,Bingjie Pan,Aleksandar Petrovic,Djuro Kosanovic,Ralph Theo Schermuly,Clemens Ruppert,Andreas Günther,Zhen Zhang,Chengfeng Qiu,Ying Li,Jun Pu,Xiaohui Li,Alex F Chen
BACKGROUND Pulmonary hypertension (PH) is a fatal progressive disease characterized by pulmonary endothelial injury and occlusive pulmonary vascular remodeling. Lysosomal protease cathepsin L degrades essential molecules to participate in the human pathophysiological process. BMPR2 (bone morphogenetic protein type II receptor) deficiency, an important cause of PH, results from mutational inactivation
-
Aortic-Femoral Stiffness Gradient and Cardiovascular Risk in Older Adults. Hypertension (IF 6.9) Pub Date : 2024-10-07 Keeron Stone,Simon Fryer,Barry J McDonnell,Michelle L Meyer,James Faulkner,Mohsen Agharazii,Catherine Fortier,Christopher J A Pugh,Craig Paterson,Gabriel Zieff,Aiden J Chauntry,Anna Kucharska-Newton,Martin Bahls,Lee Stoner
BACKGROUND The aortic-femoral arterial stiffness gradient, calculated as the ratio of lower-limb pulse-wave velocity (PWV) to central (aortic) PWV, is a promising tool for assessing cardiovascular disease (CVD) risk, but whether it predicts incident CVD is unknown. METHODS We examined the association of the aortic-femoral arterial stiffness gradient measures carotid-femoral stiffness gradient (femoral-ankle
-
Water and Electrolyte Content in Hypertension in the Skin (WHYSKI) in Primary Aldosteronism. Hypertension (IF 6.9) Pub Date : 2024-10-02 Francesca Torresan,Federico B Rossi,Ilaria Caputo,Sofia Zanin,Brasilina Caroccia,Andrea Mattarei,Michela Paccagnella,Eva Kohlscheen,Teresa M Seccia,Maurizio Iacobone,Gian-Paolo Rossi
BACKGROUND Primary aldosteronism (PA), the most common curable salt-dependent form of arterial hypertension, features renal K+ loss and enhanced Na+ reabsorption. We investigated whether the electrolyte, water, and TonEBP (tonicity-responsive enhancer binding protein)/NFAT5 (nuclear factor of activated T cells 5) content is altered in the skin of patients with PA and corrected by surgical cure. METHODS
-
Personal Genetic-Hypertension Odyssey From Phenotypes to Genotypes and Targets. Hypertension (IF 6.9) Pub Date : 2024-10-02 Friedrich C Luft
Hypertension requires increased systemic vascular resistance. Thus far, Mendelian hypertension-related genes are related to salt retention, an indirect regulatory effect. With the identification of mutated, overactive, PDE3A (phosphodiesterase 3A), we have uncovered a more direct vasoconstrictive mechanism. The autosomal-dominant syndrome features another specific phenotype, brachydactyly type E. Hypertension
-
Awakening to the Pertinence of Sleep for Hypertension. Hypertension (IF 6.9) Pub Date : 2024-09-30 Tomoyuki Tobushi,John S Floras
-
Maternal Hypertension and Fecundability: A Population-Based Cohort Study. Hypertension (IF 6.9) Pub Date : 2024-09-27 Wenxue Xiong,Lu Han,Xijia Tang,Rui Li,Wen Chen,Xiaohua Liu,Hua Nie,Weibing Qin,Li Ling
BACKGROUND The association of hypertension and blood pressure control with fecundability among women is not yet elucidated. The purpose of this study was to evaluate the hypothesis that maternal preconception hypertension would be associated with reduced fecundability and that blood pressure control could reduce excess risk. METHODS Using the National Free Preconception Checkup Projects in Guangdong
-
ENaCγ in Urinary Extracellular Vesicles as an Indicator of MR Signaling in Primary Aldosteronism. Hypertension (IF 6.9) Pub Date : 2024-09-25 Yuto Hayama,Emiko Kuribayashi-Okuma,Norihiko Fujii,Fumika Ochiai-Homma,Osamu Yamazaki,Yuya Tsurutani,Tetsuo Nishikawa,Shigeru Shibata
BACKGROUND Aldosterone and the MR (mineralocorticoid receptor) are important therapeutic targets for hypertension and cardiovascular diseases. However, biomarkers of tissue MR signaling are not fully established. Extracellular vesicles released from eukaryotic cells can provide information on tissue signaling. Using samples from patients with primary aldosteronism (PA), we explored the potential of
-
Angiotensin in the Arcuate: Mechanisms Integrating Cardiometabolic Control: The 2022 COH Mid-Career Award for Research Excellence. Hypertension (IF 6.9) Pub Date : 2024-09-24 Samuel B R Lawton,Valerie A Wagner,Pablo Nakagawa,Jeffrey L Segar,Curt D Sigmund,Lisa L Morselli,Justin L Grobe
The American Heart Association has identified obesity as a primary impediment to ongoing improvements in cardiovascular diseases, including hypertension. Although drugs, exercise, diets, and surgeries can each cause weight loss, few subjects maintain a reduced weight over the long term. Dysfunctional integrative control (ie, adaptation) of resting metabolic rate (RMR) appears to underlie this failed
-
Intact NOX2 in T Cells Mediates Pregnancy-Induced Renal Damage in Dahl SS Rats. Hypertension (IF 6.9) Pub Date : 2024-09-20 John Henry Dasinger,Justine M Abais-Battad,Samuel D Walton,Emily C Burns-Ray,Mary Cherian-Shaw,Kaitlyn E Baldwin,Daniel J Fehrenbach,David L Mattson
BACKGROUND Hypertensive disorders of pregnancy are associated with increased risk for cardiovascular disease, renal disease, and mortality. While the exact mechanisms remain unclear, T cells and reactive oxygen species have been implicated in its pathogenesis. We utilized Dahl salt-sensitive (SS), SSCD247-/- (Dahl SS CD247 knockout rat; lacking T cells), and SSp67phox-/- (Dahl SS p67phox [NOX2 (NADPH
-
Prevalence and Risk Factors for Secondary Hypertension in Young Adults. Hypertension (IF 6.9) Pub Date : 2024-09-19 Jean-Baptiste de Freminville,Margherita Gardini,Antoine Cremer,Scarlett Camelli,Stephanie Baron,Guillaume Bobrie,Philippe Gosse,Romain Boulestreau,Nicole Gebara,Julien Doublet,Thomas Dussartre,Christine Grataloup,Aurélien Lorthioir,Christine Massien,Anne-Marie Madjalian,Julien Riancho,Gilles Soulat,Nicolas Postel-Vinay,Michel Azizi,Bastien Rance,Laurence Amar
BACKGROUND The prevalence of secondary causes of hypertension in young adults is unknown, and therefore, there is no consensus about the indication of screening of secondary hypertension (2HTN) in this population. The objective was to report the prevalence and the causes of 2HTN in young subjects. METHODS In this cross-sectional study, 2090 patients with confirmed hypertension aged 18 to 40 years with
-
Clinical Trial Evidence of the Gut Microbial Metabolite Butyrate in Hypertension. Hypertension (IF 6.9) Pub Date : 2024-09-18 Leticia Camargo Tavares,Francine Z Marques
-
Navigating Hypertension in Hypertrophic Obstructive Cardiomyopathy: A Cardiovascular Conundrum. Hypertension (IF 6.9) Pub Date : 2024-09-18 Sean W Dooley,Usman A Tahir,Jennifer L Cluett
-
Association of High Blood Pressure With Post-Traumatic Stress Disorder in Ukrainian Women Refugees. Hypertension (IF 6.9) Pub Date : 2024-09-18 Anna Shalimova,Maria Simona Stoenoiu,Narcis-George Manolache,Wiesław J Cubała,Michel Burnier,Krzysztof Narkiewicz,Alexandre Persu
-
Systolic Blood Pressure, Cardiovascular Health, and Neurocognition in Adolescents. Hypertension (IF 6.9) Pub Date : 2024-09-18 Stephen R Hooper,Marc B Lande,Joseph T Flynn,Coral D Hanevold,Kevin E Meyers,Joshua Samuels,Richard C Becker,Stephen R Daniels,Bonita E Falkner,Michael A Ferguson,Julie R Ingelfinger,Lisa J Martin,Mark Mitsnefes,Phillip Khoury,Jangdong Seo,Elaine M Urbina
BACKGROUND We studied whether increased systolic blood pressure (SBP), as determined by auscultatory SBP, ambulatory SBP, and the number of cardiovascular health risk indicators, are associated with neurocognition in adolescents. METHODS This cross-sectional study included 365 adolescents (mean age, 15.5 years) from 6 academic medical centers in the United States. The sample was 59.5% male, 52.6% White
-
Dysregulated Mitochondrial Calcium Causes Spiral Artery Remodeling Failure in Preeclampsia. Hypertension (IF 6.9) Pub Date : 2024-09-18 Xiyuan Lu,Yifan Wang,Na Geng,Zhiguo Zou,Xueqing Feng,Yuehong Wang,Zhice Xu,Ning Zhang,Jun Pu
BACKGROUND Calcium deficiency in women is strongly linked to an increased risk of developing preeclampsia. Mitochondrial calcium ([Ca2+]m) homeostasis is essential to regulate vascular smooth muscle cell (VSMC) function. However, the role of [Ca2+]m in preeclampsia development remains largely unknown. METHODS To investigate this, human spiral arteries obtained from normotensive and preeclamptic women
-
To Harmonize or to Hinder … Do We Need 2 Sets of European Hypertension Guidelines in 2024? Hypertension (IF 6.9) Pub Date : 2024-09-16 Aletta E Schutte,Garry L R Jennings